- Home
- IMNM vs INSW Comparison
IMNM vs INSW Comparison
Compare IMNM & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- INSW
- Stock Information
- Founded
- IMNM 2006
- INSW 1999
- Country
- IMNM United States
- INSW United States
- Employees
- IMNM N/A
- INSW N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- INSW Semiconductors
- Sector
- IMNM Health Care
- INSW Technology
- Exchange
- IMNM Nasdaq
- INSW Nasdaq
- Market Cap
- IMNM 748.3M
- INSW 1.8B
- IPO Year
- IMNM 2020
- INSW N/A
- Fundamental
- Price
- IMNM $8.76
- INSW $38.46
- Analyst Decision
- IMNM Strong Buy
- INSW Buy
- Analyst Count
- IMNM 5
- INSW 2
- Target Price
- IMNM $26.40
- INSW $52.00
- AVG Volume (30 Days)
- IMNM 1.0M
- INSW 729.0K
- Earning Date
- IMNM 08-11-2025
- INSW 08-06-2025
- Dividend Yield
- IMNM N/A
- INSW 10.08%
- EPS Growth
- IMNM N/A
- INSW N/A
- EPS
- IMNM N/A
- INSW 6.47
- Revenue
- IMNM $10,938,000.00
- INSW $860,606,000.00
- Revenue This Year
- IMNM N/A
- INSW N/A
- Revenue Next Year
- IMNM $310.65
- INSW $2.05
- P/E Ratio
- IMNM N/A
- INSW $6.14
- Revenue Growth
- IMNM N/A
- INSW N/A
- 52 Week Low
- IMNM $5.15
- INSW $27.20
- 52 Week High
- IMNM $16.81
- INSW $58.84
- Technical
- Relative Strength Index (RSI)
- IMNM 49.51
- INSW 50.90
- Support Level
- IMNM $8.40
- INSW $36.03
- Resistance Level
- IMNM $8.99
- INSW $40.75
- Average True Range (ATR)
- IMNM 0.44
- INSW 1.32
- MACD
- IMNM -0.06
- INSW 0.00
- Stochastic Oscillator
- IMNM 43.60
- INSW 47.28
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.